BioNTech SE (BNTX) Revenue (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Revenue data on file, last reported at $1.1 billion in Q4 2025.

• For the quarter ending Q4 2025, Revenue fell 16.94% year-over-year to $1.1 billion; the trailing twelve-month figure through Dec 2025 stood at $3.3 billion (up 11.35% YoY), and the FY2025 full-year result was $3.2 billion, up 10.29% from the prior year.
• Revenue declined to $1.1 billion in Q4 2025, from $1.8 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $7.2 billion in Q3 2021 to a low of $138.6 million in Q2 2024.
• A 5-year average of $2.6 billion and a median of $1.5 billion in 2023 frame the typical range for Revenue.
• Peak annual rise in Revenue reached 13797.8% in 2021, while the deepest fall reached 100.0% in 2021.
• Tracing BNTX's Revenue over 5 years: stood at $6.3 billion in 2021, then plunged by 31.03% to $4.4 billion in 2022, then tumbled by 63.54% to $1.6 billion in 2023, then fell by 20.09% to $1.3 billion in 2024, then fell by 16.94% to $1.1 billion in 2025.
• Business Quant data shows BNTX's Revenue at $1.1 billion in Q4 2025, $1.8 billion in Q3 2025, and $295.2 million in Q2 2025.